U.S. Complex & Chronic Condition Management Market (By Disease Type: Cardiovascular Diseases, Oncology, Musculoskeletal, Women’s Health/Fertility/Maternity, Chronic Obstructive Pulmonary Disease, Others; By Service: Consulting Service, Implementation Service, Education Service, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024 – 2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Complex & Chronic Condition Management Market
5.1. COVID-19 Landscape: Complex & Chronic Condition Management Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. U.S. Complex & Chronic Condition Management Market, By Disease
8.1. Complex & Chronic Condition Management Market, by Disease Type, 2021-2027
8.1.1. Cardiovascular Diseases
8.1.1.1. Market Revenue and Forecast (2017-2027)
8.1.2. Oncology
8.1.2.1. Market Revenue and Forecast (2017-2027)
8.1.3. Musculoskeletal
8.1.3.1. Market Revenue and Forecast (2017-2027)
8.1.4. Women’s Health/Fertility/Maternity
8.1.4.1. Market Revenue and Forecast (2017-2027)
8.1.5. Chronic Obstructive Pulmonary Disease
8.1.5.1. Market Revenue and Forecast (2017-2027)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017-2027)
Chapter 9. U.S. Complex & Chronic Condition Management Market, By Service
9.1. Complex & Chronic Condition Management Market, by Service, 2021-2027
9.1.1. Consulting Service
9.1.1.1. Market Revenue and Forecast (2017-2027)
9.1.2. Implementation Service
9.1.2.1. Market Revenue and Forecast (2017-2027)
9.1.3. Education Service
9.1.3.1. Market Revenue and Forecast (2017-2027)
9.1.3.2.
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2017-2027)
Chapter 10. U.S. Complex & Chronic Condition Management Market, U.S. Estimates and Trend Forecast
10.1. U. S.
10.1.1. Market Revenue and Forecast, by Disease (2017-2027)
10.1.2. Market Revenue and Forecast, by Service (2017-2027)
Chapter 11. Company Profiles
11.1. AllScripts
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Siemens Healthineers
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Koninklijke Philips N.V.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Pegasystems, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Cognizant TriZetto Software Group Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. IBM Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. ScienceSoft USA
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. MINES & Associates, Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Healthcare at Home
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Mediware Information Systems
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample